51st Annual Meeting
SOCIETY FOR SURGERY OF THE ALIMENTARY TRACT
MAY 1 – 5, 2010
NEW ORLEANS, LOUISIANA
during Digestive Disease Week^®

Final Program

All rooms at the Morial Convention Center unless otherwise indicated.

Program and Abstracts | Posters

SSAT POSTER SESSIONS

The SSAT Poster Sessions will be held in Hall F of the Morial Convention Center, from 8:00 AM – 5:00 PM. Authors will be at their posters to answer questions from 12:00 PM to 2:00 PM.

Designated presenting authors listed. View a complete author string with abstract by clicking on the poster title.

	WEDNESDAY, MAY 5, 2010
Basic: Colon-Rectal
	P128 Local Peritoneal Irrigation with Intestinal Alkaline Phosphatase Is Protective Against Peritonitis in Mice Farzad Ebrahimi, Department of Surgery, Massachusetts General Hospital/Harvard Medical School, Boston, MA
	P129 Plasma Levels of Soluble Intercellular Adhesion Molecule-1 Are Modestly Increased in Patients with Colorectal Cancer C. M. Shantha Kumara H, Colon and Rectal Surgery, Department of Surgery, St Luke Roosevelt Hospital, New York, NY
Basic: Esophageal
	P130 Is Toupet Fundoplication the Most Physiological Procedure to Treat Gastroesophageal Reflux Disease? Results of a Prospective Randomized Experimental Trial Comparing Three Major Antireflux Operations Kai Bachmann, General Visceral and Thoracic Surgery, University Medical Center Hamburg Eppendorf, Hamburg, Germany
Basic: Pancreas
	P131 Pterostilbene and Gemcitabine Have Additive Effects Against Pancreatic Cancer in Vitro Patrick Mannal, Department of Surgery, University of Vermont/Fletcher Allen Health Care, Burlington, VT
	P132 Nitric Oxide Synthase Inhibiton Reduces the Lung Damage Induced by Albumin Administration in Acute Pancreatitis Emilio Elias Abdo, Gastroenterology, University of Sao Paulo, Sao Paulo, São Paulo, Brazil
Basic: Small Bowel
	P133 The Effects of Cannabinoids on Intestinal Permeability in an in Vitro Model of Inflammation Abdussalam Alhamoruni, School of Graduate Entry Medicine and Health, University of Nottingham, Derby, United Kingdom
Basic: Stomach
	P134 Hemoglobin A1c Levels and Obesity in a Representative US Adult Population: Findings from the National Health and Nutrition Examination Surveys, 1999-2006 Xuan-Mai T. Nguyen, Surgery, UC Irvine, Orange, CA
Clinical: Biliary
	P135 Variable Frequency of p-53, Rad-50, Cyclin-E and k-ras Gene Mutations with Mixed Chimerism of STR Loci and Their Plausible Role in the Gallbladder Carcinogenesis in a Cohort Exposed to Methyl Isocyanate Kewal Krishan Maudar, Research, Bhopal Memorial Hospital & Research Centre, Pune, Maharashtra, India
	P136 Natural Orifice Translumenal Endoscopic Surgery (NOTES): Prospective Non-Randomized Comparison of Transgastric Versus Transvaginal Cholecystectomy Eric S. Hungness, Department of Surgery, Northwestern University, Chicago, IL
	P137 Survival Patterns for Gallbladder Cancer in Recent Decades; Experience at a National Cancer Institute Veeraiah Siripurapu, Fox Chase Cancer Center, Philadelphia, PA
	P138 Patient Interest in Natural Orifice Transluminal Endoscopic Surgery (NOTES) as an Alternative to Laparoscopic Cholecystectomy Monica Tomoyo Young, Indiana University , Indianapolis, IN
	P139 Laparo-Endoscopic Single Site (LESS) Cholecystectomy with Epidural Anesthesia: A Safe, Cost Effective, and Appealing Approach Sharona B. Ross, Surgery, University of South Florida, Tampa, FL
Clinical: Colon-Rectal
	P140 Elastica Staining for Venous Invasion Results in Superior Prediction of Cancer Specific Survival in Colorectal Cancer Campbell S.D. Roxburgh, University Department of Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom
	P141 Photodynamic Diagnosis Using 5-Aminolevulinic Acid May Improve Diagnostic Accuracy of Colorectal Cancer: A Feasibility Study Yoshihisa Watayo, Department of Surgery, Institute of Gastroenterology, Tokyo, Japan
	P142 Extent of Response of Rectal Cancer to Neoadjuvant Chemoradiation Predicts Outcome Kelly Marie McLean, Gastrointestinal Oncology, Surgery, H Lee Moffitt Cancer Center and Research Institute, University of South Florida, Tampa, FL
	P143 Primary Sclerosing Cholangitis and Extra Intestinal Manifestations in Patients with Ulcerative Colitis and Ileal Pouch-Anal Anastomosis Hans H. Wasmuth, Department of Gastrointestinal Surgery, St Olavs Hospital, Trondheim University Hospital, Trondheim, Norway
	P144 Pathologic Nodal Status Is an Independent Predictor of Disease-Free Survival in Rectal Cancer Treated by Neoadjuvant Chemoradiation Jonathan Matthew Hernandez, Surgery, Gastrointestinal Oncology, USF, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
	P145 Transvaginal Specimen Extraction for Laparoscopic Colectomy Jung Kang, Colon & rectum Surgery, Tzu chi general Hospital, Hualien, Taiwan
	P146 Grade of Ischemia on Lower Endoscopy Is the Reliable Predictor of Need for Operative Intervention for Ischemic Colon in Critically Ill Patients Matthew Hughes, Surgery, University of Florida, Gainesville, FL
	P147 Do Gastroenterologists Find More Adenomas on Colonoscopy Than Colorectal Surgeons? Kevin Ollington, Gastroenterology, Cedars-Sinai Medical Center, Los Angeles, CA
	P148 A Novel Data-Driven Staging of Colorectal Cancer Elena Manilich, The Cleveland Clinic, Cleveland, OH
	P149 Diagnosis and Management of Afferent Limb Syndrome After Ileal Pouch-Anal Anastomosis Hasan Tarik Kirat, Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH
Clinical: Esophageal
	P150 Persistent Elevation of C-Reactive Protein After Gastro-Oesophageal Cancer Resection as a Predictor of Post-Operative Intra-Abdominal Infective Complications Sumanta Dutta, Department of Surgery, University of Glasgow, Glasgow, United Kingdom
	P151 Postoperative Impedance Testing Unreliable in Detecting Nissen Fundoplication Failure Brittany N. Arnold, Minimally Invasive Surgery, The Oregon Clinic, Portland, OR
	P152 Treatment of Mid and Distal Esophageal Diverticula: A Single Institution Eleven Year Experience Neal Agee, Department of GI and Minimally Invasive Surgery, Carolinas Medical Center, Charlotte, NC
	P153 The Role of PET/CT in Identifying Advanced Disease in Patients with Potentially Curable Oesophageal Carcinoma Victoria Louise Wilson, Upper GI Surgery, Glasgow Royal Infirmary, Glasgow, United Kingdom
	P154 Laparoscopic Partial Posterior (Toupet) Fundoplication in GERD Patients with Impaired Esophageal Motility: A 10 Year Follow-Up Study Including Quality of Life Heinz Wykypiel, Department of Visceral, Transplant and Thoracic Surgery, Medical University Innsbruck, Innsbruck, Austria
	P155 The Effect of an Increasing Body Mass Index on Health Related Quality of Life Following Esophago-Gastric Cancer Surgery Jiten Kalyan, General Surgery, Norfolk and Norwich University Hospital NHS Foundation Trust, Norwich, Norfolk, United Kingdom
	P156 The Relationship Between the Local and Systemic Inflammatory Responses and Survival in Patients Undergoing Curative Surgery for Gastro-Oesophageal Cancer Sumanta Dutta, Department of Surgery, University of Glasgow, Glasgow, United Kingdom
	P157 A Simple Risk Score to Predict Short-Term and Long-Term Outcome in Only Surgically Treated Esophageal Cancer Yogesh Kumar Vashist, Department of General, Visceral- and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
	P158 Technical Complications After Esophagectomy Did Not Affect the 5 Year Survival for Treatment of Squamous Esophageal Carcinoma Philip WY Chiu, Surgery, Institute of Digestive Disease, The Chinese University of Hong Kong, Hong Kong, China
	P159 Postprandial Proximal Gastric Acid Pocket in Patients After Roux-en-Y Gastric Bypass Fernando A.M. Herbella, Surgery, Federal University of Sao Paulo, Sao Paulo, Brazil
Clinical: Hepatic
	P160 The Use of Intraoperative Ablation Extends the Limits of Potentially Curative Treatment for Recurrent Colorectal Liver Metastases Anand Govindarajan, Memorial Sloan-Kettering Cancer Center, New York, NY
	P161 Age of Transfused Red Blood Cells and Outcomes After Liver Resection of Hepatocellular Carcinoma Daniel Cusati, General Surgery, Mayo Clinic, Rochester, MN
	P162 Underutilization of Surgical Treatment of Hepatocellular Carcinoma in the Medicare Population Shimul A. Shah, Surgery, University of Massachusetts Medical School, Worcester, MA
	P163 Preoperative Predictors of Increased Intraoperative Blood Loss During Hepatectomy Yusuke Yamamoto, Hepatobiliary and Pancreatic Surgery, National Cancer Center Hospital, Tokyo, Japan
Clinical: Pancreas
	P164 Tumor Size Correlates with Lymph Node Metastasis in Primary Pancreatic Endocrine Neoplasms Trevor Ellison, General Surgery, Johns Hopkins, Baltimore, MD
	P165 Intra-Abdominal Fat Predicts Survival in Pancreatic Cancer Courtney Balentine, Michael E DeBakey Department of Surgery, , Baylor College of Medicine, Michael E DeBakey Veterans Affairs Hospital, Houston, TX
	P166 Prognostic Impact of Dihydropyrimidine Dehydrogenase Expression in Adjuvant Gemcitabine Plus S-1 Chemotherapy After Surgical Resection for Pancreatic Adenocarcinoma Naru Kondo, Surgery, Department of Surgery, Division of Clinical Medical Science, Graduate School of Biomedical Sciences, Hiroshima University,, Hiroshima, Hiroshima, Japan
	P167 Palliative Treatment of Obstructive Jaundice in Patients with Carcinoma of the Pancreatic Head or Distal Biliary Tree: Endoscopic Stent Placement vs. Hepaticojejunostomy Marius Distler, Visceral-, Thoracic- and Vascular Surgery, University Hospital TU Dresden, Dresden, Germany
	P168 Serum Blood Urea Nitrogen (BUN) and Albumin on the First Post-Operative Day (POD 1) Predict Pancreatic Fistula and Major Complications After Pancreaticoduodenectomy (PD) Nathan G. Richards, Surgery, Thomas Jefferson University, Philadelphia, PA
	P169 The Prognostic Influence of Lymph Node Ratio Following Pancreaticoduodenectomy for Ampullary Adenocarcinoma Nigel Balfour Jamieson, West of Scotland Pancreatic Unit, Glasgow University Department of Surgery, Glasgow Royal Infirmary, Glasgow, Lanarkshire, United Kingdom
	P170 The Role of Procalcitonin in the Early Diagnosis of Postoperative Pancreatic Fistula After Pancreatic Resection Dominique Suelberg, Surgical Department, St. Josef-Hospital, Universitiy Hospital, Bochum, Germany
	P171 Will Ki-67 Predict Lymph Node Status in Pancreatic Endocrine Tumors? Derick Christian, Methodist Dallas Medical Center, Dallas, TX
	P172 Diagnostic Laparoscopy for Pancreatic Cancer in an MRI Driven Practice: What's It Worth? Elliot Tapper, Beth Israel Deaconess Medical Centre, Boston, MA
	P173 Advanced Disease Not a Risk Factor for Delayed Gastric Emptying After Pancreaticoduodenectomy (Whipple Procedure) Ronald Joseph Shonkwiler, Columbia University, New York, NY
	P174 Feeding Tube Placement and Relationship to Pancreaticoduodenectomy Outcome Tanya Ross Flohr, surgery, University of Virginia, Charlottesville, VA
	P175 Diagnostic of Exocrine Pancreatic Insufficiency: Fecal Elastase-1 vs. serum-beta-Carotin Dominique Suelberg, Surgical Department, St. Josef-Hospital, University Hospital, Bochum, Germany
	P176 Interventional Radiology Assisted Endoscopic Transgastric Peripancreatic Fluid Collection Drainage Abdulrahim saeed Alawashez, Surgery, Dalhousie University, Halifax, NS, Canada
	P177 The Burden of Infection for Elective Pancreatic Resections Tara Sotsky Kent, Surgery, Beth Israel Deaconess Medical Center, Boston, MA
	P178 Surgeon and Organ Matter for the Outcome After Distal Pancreatic Resection Ulrich Friedrich Wellner, Dept. for General and Visceral Surgery, University of Freiburg, Freiburg, BW, Germany
Clinical: Small Bowel
	P179 Electrical Stimulation of the Duodenum to Treat Diabetes Mellitus Typ 2 in Obese Patients: Preliminary Results of the First in Men Study Philipp Busch, General, Visceral and Thoracic Surgery, University Medical Center Hamburg, Hamburg, Germany
Clinical: Stomach
	P180 Risk of Obesity-Related Cancer After Obesity Surgery in a Population-Based Cohort Study Magdalena Plecka Östlund, Dept. of Molecular Medicine and Surgery, Karolinska Institute, Upper Gastrointestinal Research, Stockholm, Sweden
	P181 Anatomical Analysis of the Gastric Drainage Lymph Nodes of Normal Subjects Andre Luis Bonini, Surgery, Federal University of São Paulo, São Paulo, São Paulo, Brazil
	P182 Laparoscopic Total Gastrectomy (LATG) and Roux-en-Y Reconstruction Using Oro-Gastric Anvil, Over 80 Cases Experiences Hitoshi Satodate, Digestive Disease Center, Showa University Northern Yokohama Hospital, Yokohama, Japan
	P183 Clinical Experience of Gastric Tube Reconstruction with the Transoral Anvil After Laparoscopy–Assisted Proximal Gastrectomy Yoko Wada, Digestive desease , Showa-University Northern Yokohama Hosp, Yohama, Japan
	P184 Idiopathic Gastrointestinal Failure Syndrome in Female Smokers with Peptic Ulcer Disease Sebastian G. de la Fuente, Duke University Medical University, Durham, NC
	P185 Gastrotomy Closure in NOTES: Literature Review and Description of the Clinical NOTES Gastrotomy Closure Technique Kari Thompson, Surgery, University of California San Diego, San Diego, CA
Combined Science
	P186 A Combined Oral Regimen of EGCG and Silibinin Inhibited the Subcutaneous Growth of the CT-26 Colon Cancer Cell Line and Had No Adverse Effect on Abdominal or Gastric Wound Healing Xiaohong Yan, Colon and Rectal Surgery, St Luke Roosevelt Hospital, New York, NY
	P187 Single-Incision Laparoscopic Surgery (SILS) Simulator Training Improves Performance Byron F. Santos, Department of Surgery, Northwestern University, Chicago, IL
	P188 Increased Gastric Conduit Ischemia as Measured by Optical Fiber Spectroscopy During Minimally Invasive Esophagectomy Is Associated with Development of Anastomotic Complications Thai Hong Pham, Portland, OR